TFS International AB

TFS is a full-service, mid-sized Contract Research Organization (CRO) with global-reach, partnering with biotechnology and pharmaceutical companies around the world. We provide flexible customer-tailored solutions with in-depth oncology experience, and local regionally/country-based oncology resources wherever needed, for customized highly specialized immunotherapy trials. These solutions include clinical expertise with several antibodies, checkpoint inhibitors, cell and gene therapy, vaccines and oncolytic virus, used as a monotherapy product or in combination therapy. Our extensive experience in immuno-oncology cover all clinical phases, and across solid tumor and malignant hematology indications as well. Partnering with TFS’ Oncology & Hematology Business Unit could bring substantial benefits to your trials, which include the following:

 

·        In-depth global experience in the key therapeutic areas

·        Therapeutic, scientific and strategic excellence

·        Regulatory submissions excellence

·        Operational delivery excellence

·        Ensuring consistency and standardization across all your trials

·        Providing a collaborative approach for our customers to work with skilled TFS staff who have solid relevant therapeutic experience, and who understand the unique complexities around their protocols and study designs

 

With nearly 700 professionals, and clinical services in than 40 countries, TFS supports our customers with comprehensive solutions and flexible, strategic resourcing.

TFS demonstrates scientific and medical competence across a broad therapeutic spectrum, with industry-leading capabilities in:

·        Hemato-Oncology

·        Dermatology, Immunology and Inflammatory Diseases

·        Ophthalmology

·        Internal Medicine and Neurology